Fig. 8

TMB analyses and drug sensitivity between high- and low-risk groups. (A-B) Waterfall plots displaying the mutation rates of the top 15 mutated genes of the low- (A) and high-risk groups (B). (C). The K-M curves of glioma patients in the TMB level-high and -low groups. (D). The K-M curves of the four subgroups based on the risk score and TMB levels. (E). The difference in TMB between high- and low-risk groups. (F-H). The box plot exhibiting drug sensitivity of bexarotene, embelin and shilkonin between high- and low-risk groups